Literature DB >> 16760680

Clinical and nonclinical correlates of adherence to prescribing guidelines for hypertension in a large managed care organization.

Philip C Skelding1, Sumit R Majumdar, Ken Kleinman, Cheryl Warner, Susanne Salem-Schatz, Irina Miroshnik, Lisa Prosser, Steven R Simon.   

Abstract

To examine correlates of guideline adherence in a population with access to health care and prescription drug benefits, the authors conducted a cross-sectional analysis among 5789 patients undergoing hypertension treatment with a single medication in a large New England managed care organization. Logistic regression was used to determine correlates of adherence, defined as use of diuretics or beta blocker as antihypertensive monotherapy during the 1-year study period. Women were more likely than men to receive guideline-adherent therapy (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.45-1.85). Compared with patients covered by health maintenance organization plans, Medicare coverage was positively associated with guideline adherence (OR, 1.38; 95% CI, 1.13-1.69), but fee-for-service coverage was negatively associated (OR, 0.66; 95% CI, 0.48-0.91). Patient age was not a significant correlate of adherence to guidelines (OR, 1.01; 95% CI, 0.94-1.09). Understanding these observations may lead to strategies to improve guideline adherence and reduce health care disparities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760680      PMCID: PMC8109477          DOI: 10.1111/j.1524-6175.2006.05337.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

1.  Hypertension management of medical aid patients attending private practices.

Authors:  P R Edwards; K Steyn; L Walters; A Smart; S Gammon; C J Lombard
Journal:  S Afr Med J       Date:  1999-02

2.  Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control.

Authors:  Stephen B Soumerai; Connie Mah; Fang Zhang; Alyce Adams; Mary Barton; Vera Fajtova; Dennis Ross-Degnan
Journal:  Arch Intern Med       Date:  2004-03-22

3.  Hypertension in adults across the age spectrum: current outcomes and control in the community.

Authors:  Donald M Lloyd-Jones; Jane C Evans; Daniel Levy
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

4.  The influence of national guidelines on antihypertensive prescribing patterns.

Authors:  D Siegel
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

5.  Hypertension guidelines and their limitations--the impact of physicians' compliance as evaluated by guideline awareness.

Authors:  J Hagemeister; C A Schneider; S Barabas; R Schadt; G Wassmer; G Mager; H Pfaff; H W Höpp
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

6.  Rational pharmacotherapy of hypertension in the elderly: analysis of the choice and dosage of drugs.

Authors:  K A Jassim Al Khaja; R P Sequeira; V S Mathur
Journal:  J Clin Pharm Ther       Date:  2001-02       Impact factor: 2.512

7.  Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.

Authors:  David Williams; Kathleen Bennett; John Feely
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

8.  Hypertension guidelines in elderly patients: is anybody listening?

Authors:  Karen Tu; Muhammad M Mamdani; Jack V Tu
Journal:  Am J Med       Date:  2002-07       Impact factor: 4.965

9.  Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

Authors:  Randall S Stafford; Curt D Furberg; Stan N Finkelstein; Iain M Cockburn; Tseday Alehegn; Jun Ma
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

10.  Is there a clinically significant gender bias in post-myocardial infarction pharmacological management in the older (>60) population of a primary care practice?

Authors:  Romolo Di Cecco; Umesh Patel; Ross E G Upshur
Journal:  BMC Fam Pract       Date:  2002-05-03       Impact factor: 2.497

View more
  2 in total

1.  Association of Healthcare Plan with atrial fibrillation prescription patterns.

Authors:  Andrew Young Chang; Mariam Askari; Jun Fan; Paul A Heidenreich; P Michael Ho; Kenneth W Mahaffey; Aditya Jathin Ullal; Alexander Carroll Perino; Mintu P Turakhia
Journal:  Clin Cardiol       Date:  2018-09-22       Impact factor: 2.882

Review 2.  Compliance and fixed-dose combination therapy.

Authors:  Sripal Bangalore; Anupama Shahane; Sanobar Parkar; Franz H Messerli
Journal:  Curr Hypertens Rep       Date:  2007-06       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.